Ken Griffin Biotechnology

Citadel Advisors LLC

  • $505 Billion
  • Q3 2024

Stock List

Stock Option Type Value Options Held Last Trade Trade History
CRMD
Cor Medix Inc.
PUT
$1.65 Million
205K
Q3 2024
Added 233.46%
IONS
Ionis Pharmaceuticals Inc
PUT
$1.59 Million
39.6K
Q3 2024
Reduced 36.02%
JAZZ
Jazz Pharmaceuticals PLC
PUT
$1.58 Million
14.2K
Q3 2024
Added 171.04%
CLDX
Celldex Therapeutics, Inc.
PUT
$1.58 Million
46.5K
Q3 2024
Added 163.78%
ARWR
Arrowhead Pharmaceuticals, Inc.
PUT
$1.58 Million
81.4K
Q3 2024
Added 24.16%
AVXL
Anavex Life Sciences Corp.
CALL
$1.52 Million
267K
Q3 2024
Reduced 94.29%
VCEL
Vericel Corp
CALL
$1.47 Million
34.8K
Q3 2024
Added 686470.0%
BEAM
Beam Therapeutics Inc.
PUT
$1.45 Million
59.1K
Q3 2024
Added 94.52%
LEGN
Legend Biotech Corp
CALL
$1.43 Million
29.3K
Q3 2024
Reduced 8.88%
KRYS
Krystal Biotech, Inc.
PUT
$1.42 Million
7.8K
Q3 2024
New holding
ALT
Altimmune, Inc.
PUT
$1.33 Million
216K
Q3 2024
Added 41779.24%
ITOS
I Teos Therapeutics, Inc.
PUT
$1.32 Million
130K
Q3 2024
Added 77.28%
CAPR
Capricor Therapeutics, Inc.
PUT
$1.28 Million
83.9K
Q2 2024
Added 117.23%
RARE
Ultragenyx Pharmaceutical Inc.
PUT
$1.25 Million
22.5K
Q3 2024
Reduced 72.43%
VERA
Vera Therapeutics, Inc.
PUT
$1.23 Million
27.9K
Q3 2024
Reduced 33.99%
ACAD
Acadia Pharmaceuticals Inc
CALL
$1.23 Million
80K
Q3 2024
Reduced 74.37%
CDMO
Avid Bioservices, Inc.
PUT
$1.23 Million
108K
Q3 2024
Added 10.75%
NTLA
Intellia Therapeutics, Inc.
CALL
$1.22 Million
59.2K
Q3 2024
Added 29.73%
GERN
Geron Corp
PUT
$1.19 Million
263K
Q3 2024
Added 106.64%
AKRO
Akero Therapeutics, Inc.
CALL
$1.18 Million
41.2K
Q3 2024
Reduced 62.06%
KYMR
Kymera Therapeutics, Inc.
CALL
$1.16 Million
24.6K
Q3 2024
Reduced 60.09%
MRUS
Merus N.V.
CALL
$1.16 Million
23.3K
Q3 2024
Added 20.55%
MIRM
Mirum Pharmaceuticals, Inc.
PUT
$1.16 Million
29.8K
Q3 2024
Reduced 12.25%
KALV
Kal Vista Pharmaceuticals, Inc.
PUT
$1.13 Million
98K
Q3 2024
Added 576.07%
MNKD
Mannkind Corp
PUT
$1.13 Million
180K
Q3 2024
Reduced 33.6%
NUVL
Nuvalent, Inc.
CALL
$1.13 Million
11K
Q3 2024
Added 4093.6%
LGND
Ligand Pharmaceuticals Inc
CALL
$1.08 Million
10.8K
Q3 2024
Reduced 48.02%
TERN
Terns Pharmaceuticals, Inc.
CALL
$1.08 Million
129K
Q3 2024
Added 151.6%
BCRX
Biocryst Pharmaceuticals Inc
PUT
$1.08 Million
142K
Q3 2024
Reduced 12.21%
VRDN
Viridian Therapeutics, Inc.\De
PUT
$1.07 Million
47.2K
Q3 2024
Added 440.1%
SWTX
Spring Works Therapeutics, Inc.
PUT
$1.07 Million
33.3K
Q3 2024
Added 33.44%
BCRX
Biocryst Pharmaceuticals Inc
CALL
$1.06 Million
140K
Q3 2024
Reduced 12.21%
AUPH
Aurinia Pharmaceuticals Inc.
CALL
$1.04 Million
142K
Q3 2024
Reduced 41.69%
SNDX
Syndax Pharmaceuticals Inc
PUT
$1.04 Million
53.8K
Q3 2024
Reduced 82.09%
MRUS
Merus N.V.
PUT
$999,000
20K
Q3 2024
Added 20.55%
LEGN
Legend Biotech Corp
PUT
$989,000
20.3K
Q3 2024
Reduced 8.88%
LQDA
Liquidia Corp
PUT
$984,000
98.4K
Q3 2024
New holding
CRNX
Crinetics Pharmaceuticals, Inc.
PUT
$980,000
19.2K
Q3 2024
Added 10.88%
APLT
Applied Therapeutics Inc.
CALL
$968,000
114K
Q3 2024
Added 362.35%
ADMA
Adma Biologics, Inc.
PUT
$965,000
48.3K
Q2 2024
Reduced 89.7%
GERN
Geron Corp
CALL
$958,000
211K
Q3 2024
Added 106.64%
RNA
Avidity Biosciences, Inc.
PUT
$900,000
19.6K
Q2 2024
Added 55.89%
OCUL
Ocular Therapeutix, Inc
PUT
$869,000
99.9K
Q3 2024
Added 5.08%
AKRO
Akero Therapeutics, Inc.
PUT
$854,000
29.8K
Q3 2024
Reduced 62.06%
TVTX
Travere Therapeutics, Inc.
CALL
$853,000
61K
Q3 2024
Added 21.05%
SAGE
Sage Therapeutics, Inc.
CALL
$851,000
118K
Q3 2024
Added 30.35%
IMCR
Immunocore Holdings PLC
CALL
$849,000
27.3K
Q3 2024
Reduced 74.18%
TECH
Bio Techne Corp
PUT
$839,000
10.5K
Q3 2024
Added 366.96%
ARQT
Arcutis Biotherapeutics, Inc.
CALL
$834,000
89.7K
Q3 2024
Added 3.36%
Filter Shares Options
Ken Griffin

Ken Griffin

Ken Griffin is the founder and CEO of Citadel Advisors, a successful investment firm that uses technology and data-driven approaches to investing. Griffin is known for his expertise in quantitative investing and his innovative approach to investing. He has generated strong returns for his clients over the long term.
Track Ken Griffin's portfolio
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email